ARCHIVES

ASCO’s Lichter Says. Dingell, Stupak Urge FDA To “Act With Due Haste To Avoid Endangering Patients” Steered To ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 09 | March 7, 2008

Download PDF Visit The Full Archive

Related Articles

Arbuck Leaves NCI to Guide BMS Oncology Pipeline.

September 7, 2001

NCI Plans $38 Million For New Research In Tobacco Control Over Next Two Years

October 16, 1998

NTP Board Approves Concept For New Mutagenesis Assays

January 1, 1988

Program Announcement Completes NCI switch To Control Research

April 16, 1982

Preliminary Study Results Show DES In Utero Exposure May Not Be Threat Originally Feared

February 17, 1978

NIH begins transition to electronic grant submissions; seeks comment on options for NRSA funding.

October 28, 2005